SEC Form 4 · accession 0000891293-15-000052
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Phillip M Nudelman Ph.D.
Director
Period of report
Sep 29, 2015
Accepted (ET)
Oct 1, 2015 · 7:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 29, 2015 | S | 480 | $1.453 | D | 491,694 | D | |
| Common Stock | Sep 29, 2015 | S | 1,000 | $1.451 | D | 490,694 | D | |
| Common Stock | Sep 29, 2015 | S | 12,900 | $1.45 | D | 477,794 | D | |
| Common Stock | Sep 30, 2015 | S | 135,620 | $1.45 | D | 342,174 | D |
Table II — derivative securities
No Table II lines on this filing.